Category: Stock Market

  • A dividend upside to drive the Fortescue (ASX:FMG) share price?

    Mining ASX share price on watch represented by miner making screen with hands

    The Fortescue Metals Group Ltd (ASX: FMG) share price is heating up again after a ~20% tumble between late February and late March. The Fortescue share price is up 10% in the past month, defying expectations that iron ore prices might retreat from decade highs.

    Bell Potter believes iron ore will continue to defy expectations and upgraded Fortescue on  23 April from hold to buy with a $23.85 target price. The broker believes the dividend upside outweighs the potential iron ore price downside.

    Here’s what the broker had to say about another potential Fortescue share price run. 

    Iron ore continues to outperform 

    The research note said that the “iron ore price has continued to defy bearish forecasts (including ours) predicated on recovering supply from Brazil, restrictions being placed on certain sectors within the Chinese steel industry, potential slowing of stimulus spending on infrastructure and construction there and negative jawboning by the Chinese Industry Ministry.”

    The broker highlights a number of factors buoying iron ore prices including strong global steel demand and Chinese steel production, disappointing iron ore production out of Brazil and lower end of guidance ranges for Australian March quarter production. 

    The broker made a modest cut to FY21 product forecasts due to lower shipping volumes reported out of Port Hedland for the March 2021 quarter. Weighing in both opinions, Bell Potter upgraded its near-term iron ore price forecasts by 23%, 43% and 11% for FY21, FY22 and FY23 respectively.

    Buy the Fortescue share price for dividends 

    Bell Potter has described that in a yield-hungry environment, Fortescue’s dividend has been “a tangible price support in the face of the downside risks to the iron ore price”.

    With an improved near-term for iron ore prices, the broker believes a prospective 12-month dividend payout of A$4.01 including a final FY21 payment of A$2.41 is likely. This could represent an eye-watering yield of 18.5%.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Motley Fool contributor Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post A dividend upside to drive the Fortescue (ASX:FMG) share price? appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/2RSUsfh

  • Australian Primary Hemp (ASX:APH) share price surges 7% on new deal

    cannabis leaves on a rising line graph representing growth of ASX cannabis share price

    The Australian Primary Hemp Ltd (ASX: APH) share price is performing strongly during early-afternoon trade. This comes after the company announced it has teamed up with Annex Foods, an Australian-owned health and snack food company.

    At the time of writing, the premium plant-based and wellness company’s shares are fetching 45 cents, up 7.14%.

    New partnership agreement

    Australian Primary Hemp shares are on the move, with investors appearing upbeat about the company’s future prospects.

    According to this morning’s release, Australian Primary Hemp has signed a 2-year exclusive agreement with Annex Foods. This follows close collaboration between the two companies in helping expand Australian Primary Hemp’s market presence.

    Under the deal, Australian Primary Hemp will supply its Australian-grown and processed Hammer Milled Hemp Meal to Annex Foods. This will be used exclusively as an ingredient for products under Annex’s ‘Red Tractor’ brand. Red Tractor is a well-recognised health food brand that is sold across leading supermarkets in Australia, and overseas in ten countries.

    The latest agreement is expected to generate revenue of $250,000 for Australian Primary Hemp over the next two years.

    Management comments

    Australian Primary Hemp managing director and CEO Neale Joseph welcomed the new deal, saying:

    We believe that this second agreement with Annex demonstrates our ability to meet customer needs in terms of product quality and customer service. The partnership with Annex continues our strategy of delivering great customer outcomes with Australian grown produce.

    Annex managing director Kane Fetterplace went on to add:

    Annex Foods is committed to using Australian grown ingredients in our products and is delighted to partner with progressive companies like APH. The agreement extends our range of Red Tractor Australian grown grains and seeds to include world class hemp products.

    Australian Primary Hemp share price summary

    Australian Primary Hemp shares have fared particularly well since the beginning of November 2020 and are up 150% in just 6 months. Looking at year-to-date performance, the company’s shares have gained around 29%.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Australian Primary Hemp (ASX:APH) share price surges 7% on new deal appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3nmeJpk

  • Why the Downer (ASX:DOW) share price is rising today

    dividend shares

    The Downer EDI Limited (ASX: DOW) share price is rising today after the company announced the sale of its tyre business Otraco to the market. Shares in the company are up 1.76% and are currently sitting at $5.49.

    The Downer share price has been relatively flat so far this year, returning 0.64% compared to the 5.3% rise in the All Ordinaries Index (ASX: XAO). 

    What happened

    This morning industrial company Downer announced that it has entered into an agreement to sell its tyre management business, Otraco. The sale of Otraco is to Japanese company Bridgestone for $79 million.

    The completion of the transaction, which is subject to regulatory approvals and other conditions, is expected to occur before the end of 2021.

    Furthermore, the sale follows Downer’s strategy of divesting its mining business as part of its renewed focus on Urban services.

    Management comments

    Downer CEO Grant Fenn welcomed the news, saying:

    The sale of Otraco follows Downer’s exit from its Underground mining, Open Cut Mining West, Downer Blasting Services and Snowden consulting businesses and also our share in the RTL Mining and Earthworks joint venture.

    Potential future sales

    The CEO went on to talk about possible future sales, as the company looks to continue its divestment in its mining businesses.

    According to the release the company is in ongoing discussions to sell its open cut mining business. Fenn stated that a number of parties are interested.

    Moreover, the sale follows a number of large recent deals, which will deliver total proceeds of $605 million when concluded. To date $476 million has been received.

    About the Downer share price

    Downer is a services provider based in Australia and New Zealand. Listed on the ASX in 1998, the company is also a member of the S&P/ASX 100 Index (ASX: XTO).

    The company’s shares have been performing well in the last month on the back of a large contract win. As such, the Downer share price is up 7% for the period.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Motley Fool contributor Daniel Ewing has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Why the Downer (ASX:DOW) share price is rising today appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3tRw9N1

  • Is the Temple & Webster (ASX:TPW) share price a bargain buy?

    investor staring off as if wondering about asx share price

    The Temple & Webster Group Ltd (ASX: TPW) share price has been a poor performer in recent months and particularly last week.

    During the five days, the online furniture and homewares retailer’s shares tumbled 12%.

    And while the Temple & Webster share price is pushing higher today, it is still down 31% from its 52-week high.

    Why did the Temple & Webster share price crash lower?

    Investors were selling the company’s shares last week after the release of its third quarter update

    Although Temple & Webster is still performing positively and growing its sales strongly, it warned that it would now be focusing on growing its market share at the expense of margins.

    This includes increasing its marketing spend to build strong brand awareness and achieve a national brand status and using “tactical” pricing and promotions to increase conversion.

    Temple & Webster’s CEO & Co-Founder, Mark Coulter, explained: “You only need to look at the US to see how the e-commerce market is playing out, and why we remain bullish about the shift from offline to online. We are at the start of this once in a generation shift, and now is the time to put our foot down to secure market leadership and ensure we are the brand for the next generation of furniture shopper.”

    Is this a buying opportunity for investors?

    According to a note out of Bell Potter, its analysts have retained their hold rating and put an $11.30 price target on its shares.

    Based on the latest Temple & Webster share price, this implies potential upside of 16.5%. So while the broker only rates its shares as a hold, the returns on offer are still above-average.

    Elsewhere, analysts at Morgan Stanley are a lot more positive on the Temple & Webster share price.

    According to a note from last week, the broker has retained its overweight rating and lifted its price target to $15.00. Morgan Stanley believes its reinvestment plan makes strategic sense and expects it to widen its moat.

    Its price target implies potential upside of greater than 50% over the next 12 months.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Temple & Webster Group Ltd. The Motley Fool Australia has recommended Temple & Webster Group Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Is the Temple & Webster (ASX:TPW) share price a bargain buy? appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3nkYJE0

  • These are the 10 most shorted shares on the ASX

    most shorted shares

    At the start of each week I like to look at ASIC’s short position report to find out which shares are being targeted by short sellers.

    This is because I believe it is well worth keeping a close eye on short interest levels as high levels can sometimes be a sign that something isn’t quite right with a company.

    With that in mind, here are the 10 most shorted shares on the ASX this week according to ASIC:

    • Tassal Group Limited (ASX: TGR) is now the most shorted share after its short interest rose slightly to 9.9%. This seafood company has been targeted by short sellers due to weak salmon prices and concerns over the Australia-China trade war.
    • Resolute Mining Limited (ASX: RSG) has seen its short interest rise week on week again to 9.8%. Short sellers have been going after this gold miner due to its weak production, disappointing guidance, and issues at its Bibiani operation in Ghana.
    • Webjet Limited (ASX: WEB) is no longer the most shorted ASX share after its short interest reduced to 9.8%. Nevertheless, this is still a high level of short interest and appears to be down to concerns over the travel market recovery and its valuation.
    • Flight Centre Travel Group Ltd (ASX: FLT) has short interest of 9.2%, which is up slightly week on week. Once again, this appears to have been driven by concerns over its valuation and the stalling travel market recovery.
    • Inghams Group Ltd (ASX: ING) has 8.3% of its shares held short, which is flat week on week. An unfavourable shift in its sales mix and the exit of its CEO could be weighing on investor sentiment.
    • Metcash Limited (ASX: MTS) has seen its short interest ease slightly to 7.3%. Concerns over a potential supermarket price war and its high capital expenditure plans could be behind this.
    • Zip Co Ltd (ASX: Z1P) has entered the top ten with short interest of 7.2%. Short sellers are going after the buy now pay later provider despite it reporting strong growth during the third quarter. Valuation concerns could be weighing on sentiment.
    • Megaport Ltd (ASX: MP1) has short interest of 6.8%, which is up again week on week. Unfortunately for short sellers, the Megaport share price surged higher last week after it released a solid third quarter update.
    • Temple & Webster Group Ltd (ASX: TPW) has seen its short interest remain flat at 6.1%. Short seller will have been pleased to see the online furniture and homewares retailer’s shares sink lower last week after revealing plans to invest materially in its growth at the expense of margins.
    • Alkane Resources Limited (ASX: ALK) is back in the top ten with 6% of its shares held short. Investors appear disappointed with the slow progress the company is making with its rare earths project.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends MEGAPORT FPO. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Temple & Webster Group Ltd and ZIPCOLTD FPO. The Motley Fool Australia owns shares of and has recommended Webjet Ltd. The Motley Fool Australia has recommended Flight Centre Travel Group Limited, MEGAPORT FPO, and Temple & Webster Group Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post These are the 10 most shorted shares on the ASX appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3dRL2ti

  • 2 small cap ASX shares that are growing quickly

    man standing with arms crossed in front of giant shadow of body builder representing asx small cap stocks

    Small cap ASX shares have the potential to be able to grow quickly.

    They’re starting from a smaller base and can have a much longer growth runway as they expand into new markets and hopefully grow profit margins.

    These two businesses are demonstrating a lot of growth right now:

    Audinate Group Ltd (ASX: AD8)

    Audinate wants to pioneer the audio sector with its Dante audio-over-IPO networking solution, which it says is a world leader and used extensively in the professional live sound, commercial installation, broadcast, public address and record industries.

    How does it work? Dante can replace the analogue audio cables by transmitting synchronised audio signals to multiple locations by using an ethernet cable.

    The small cap ASX share recently revealed its FY21 third quarter which showed revenue growth of 31% to US$7 million.

    Audinate explained that this latest quarter benefited from channel fill of newly released Bluetooth and USB-C AVIO adaptors, as well as an increase in orders from customers managing global supply chain concerns.

    Compared to the first half of FY21, there has been continued strength of chips, cards and modules revenue.

    However, there’s still potential supply chain problems. Audinate CEO Aidan Williams said:

    We are closely watching global supply chains for potential negative impacts on both our customers and Audinate, which may constrain our near-term revenue and growth.

    Along with our manufacturing and OEM partners, we are working to mitigate supply chain challenges and expect this near-term uncertainty to resolve itself as CY21 progresses. We remain very confident in the long-term outlook for the business.

    Healthia Ltd (ASX: HLA)

    Healthia is Australia’s largest allied health business and owns 30 brands. It operates across different sectors in healthcare – feet and ankles, bodies and minds, and eyes and ears.

    It wants to deploy a minimum of $20 million of capital each year to buy now allied health business acquisitions. Healthia has successfully grown to the size it is through acquisitions, as well as organic growth.

    The small cap ASX share is working on new business opportunities through cross-referrals between Healthia’s businesses to promote better patient outcomes. It also wants to provide clinicians with industry leading education, tools and support and continue to develop industry leading career opportunities for all team members. This is expected to continue to drive strong organic performance into the future.

    In the FY21 half-year result, Healthia generated organic revenue growth of 14.5%, though total revenue went up 38.9%. Underlying earnings before interest, tax, depreciation and amortisation (EBITDA) grew 90.7% to $11 million, partly thanks to the underlying EBITDA margin rising 486 basis points to 17.87%. Underlying earnings per share (EPS) grew by 78.2% to 6.86 cents.

    The board are confident on the balance sheet, which is why the business is now paying a dividend. The interim dividend payment to shareholders was 2 cents per share.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of and has recommended AUDINATEGL FPO. The Motley Fool Australia has recommended HEALTHIA FPO. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post 2 small cap ASX shares that are growing quickly appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3etBBPL

  • Advanced Human Imaging (ASX:AHI) share price wobbles on agreement

    medical asx share price represented by doctor looking up at question marks

    Advanced Human Imaging Ltd (ASX: AHI) shares have been up and down today following news of a signed marketing agreement. The Advanced Human Imaging share price opened slightly higher following the news before slumping 3.35% to $1.73. 

    However, at the time of writing, the company’s shares have recovered to trade at $1.82, up 1.68% for the day so far.

    What did Advanced Human Imaging announce?

    Advanced Human Imaging shares are on a rollercoaster today after the company advised it has entered into a marketing agreement with China-Based, Tinjoy Biotech (Tinjoy).

    The partnership will see Advanced Human Imaging’s CompleteScan product integrate with Tinjoy’s WinScan app in China. Launch of the combined offering is being targeted for July 2021.

    Brought to market in 2020, Tinjoy’s WinScan app services roughly 28 million consumers every month in China. The digital health platform specialises in multiple segments of personal and population health as well as medical and preventative care. The company uses data analytics for the early detection and health assessment of individuals at risk of chronic disease.

    Under the terms of the binding sheet, Advanced Human Imaging will contribute US$200,000 over three tranches. The funds will be used towards the training of 500 call centre team members to sell the CompleteScan integration. In addition, the remaining monies will be allocated towards material production and the launch of the CompleteScan integrated WinScan app.

    Advanced Human Imaging is hoping to achieve 1 million active monthly users within the first year of the signed agreement.

    Judging by today’s Advanced Human Imaging share price moves, it seems investors have mixed feelings over the significance of the company’s news.

    What did management say?

    Vlado Bosanac, chair and CEO of Advanced Human Imaging, commented:

    Our teams have been in constant communications over the last 8 weeks progressing the application integration points. We are fortunate to have mandarin speaking staff that are able to navigate the language barrier seamlessly…

    The sheer size of the population and the high level of mobile device usage in China, gives me tremendous confidence in the acceptance of our unique and easy to use technology. I believe this will culminate in a very successful partnership.

    About the Advanced Human Imaging share price

    Including today’s gains, the Advanced Human Imaging share price has rallied by around 1,000% over the last 12 months. The company’s shares are, however, still sitting below their 52-week high of $2.19 reached in March this year.

    Advanced Human Imaging has a market capitalisation of around $238 million.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Advanced Human Imaging (ASX:AHI) share price wobbles on agreement appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/2Qpw0SC

  • Peninsula (ASX: PEN) share price jumps on update

    hand on touch screen lit up by a share price chart moving higher

    The Peninsula Energy Ltd (ASX: PEN) share price has jumped 4% higher in morning trade to 13 cents apiece. Investors are watching the company’s share price after the uranium miner released its quarterly report.

    Let’s take a look at how Peninsula performed for the last quarter.

    Peninsula releases quarterly activities report

    Earlier today, Peninsula released its quarterly activities report for the March quarter.

    The company reported an operating cash loss of US$2.2 million for the quarter with no sales recorded.  For the 9 months to 31 March, Peninsula noted an operating cash loss of US$5.7 million on sales of US$3.4 million.

    For the March quarter, Peninsula highlighted US$6.8 million cash on hand. In addition, the company also provided a summary of its purchase agreements. For the calendar year of 2022, Peninsula noted that it has entered into binding contracts for the delivery of 450,000 pounds of uranium. As a result, Peninsula forecasts a net cash margin of US$8 million to US$9 million in 2022.

    Peninsula also highlighted the company’s upgrade to the OTCQB Venture Market earlier this year.

    More on the Peninsula share price

    Peninsula is an ASX-listed uranium mining company. The company’s flagship Lance Project located in Wyoming, USA is the only US-based uranium project using a low pH, in-situ recovery (ISR).

    In order to ‘decarbonise’ the country’s power sector, the US Department of Energy has allocated US$75 million towards the establishment of a national strategic uranium reserve. As a result, Peninsula is in a position to potentially benefit from various initiatives of the US government.

    The Peninsula share price bolted out of the blocks in 2021, hitting 18 cents in mid-February. After dipping since then, the company’s share price has struggled to gain traction. Shares in Peninsula were given a boost earlier this month after the company delivered favourable results from field demonstration tests at its Lance Project. However, despite the slew of updates the Peninsula share price has tanked more than 20% in the past 12 months.

    As highlighted before, shares in Peninsula Energy were upgraded to the middle tier of the OTC market earlier this year. The upgrade was in response to strong trading volumes and provides overseas investors greater access to securities in Peninsula Energy.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Motley Fool contributor Nikhil Gangaram has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Peninsula (ASX: PEN) share price jumps on update appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3vjQ1Zv

  • Why Doctor Care Anywhere, Next Science, NIB, & Talga are charging higher

    A happy smiling kid points his fingers up, indicating a rising share price

    In early afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week on a subdued note. At the time of writing, the benchmark index is down 0.1% to 7,050.8 points.

    Four ASX shares that are not letting that hold them back are listed below. Here’s why they are charging higher:

    Doctor Care Anywhere Group PLC (ASX: DOC)

    The Doctor Care Anywhere share price is up almost 4% to $1.07. This follows the release of the telehealth company’s first quarter update. For the three months ended 31 March, Doctor Care Anywhere reported a 16.5% increase in unaudited underlying revenue to 4.4 million pounds (A$6.87 million). This was driven partly by a 14.7% increase in sign-ups to the platform to 500,000 and a 21.9% increase in consultations delivered to 90,500.

    Next Science Ltd (ASX: NXS)

    The Next Science share price has rocketed 25% higher to $1.78. Investors have been fighting to get hold of the medical device company’s shares after the US FDA approved its XPerience No Rinse Antimicrobial Solution. The XPerience product is inserted into a surgical site, which is then closed, to fight infection for up to several hours afterwards. Management believes the product can be used in every open surgery.

    NIB Holdings Limited (ASX: NHF)

    The NIB share price is up 10% to $5.91 after providing guidance for FY 2021. According to its trading update, the private health insurer has been performing positively during the second half. As a result, it expects to report underlying operating profit of $200 million to $225 million in FY 2021. This will be a big lift from the first half, when it posted underlying operating profit of $86.9 million.

    Talga Group Ltd (ASX: TLG)

    The Talga share price has jumped 25% to $1.71. This appears to be a delayed reaction to the company providing an update on its electric vehicle anode (EVA) qualification plant last week. According to the release, designs for the plant have been finalised and engineering work is progressing well. Talga has now placed orders for materials and equipment and hopes to commence its EVA plant’s installation in the fourth quarter of 2021.

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and recommends Doctor Care Anywhere Group PLC. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Nexus Energy Limited. The Motley Fool Australia has recommended Doctor Care Anywhere Group PLC and NIB Holdings Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post Why Doctor Care Anywhere, Next Science, NIB, & Talga are charging higher appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3ezxTnJ

  • This broker thinks you should buy the Kogan (ASX:KGN) share price dip

    A figure on a graph tries to rescue a falling share price

    ASX e-commerce shares are being shot down left, right, and centre after COVID-19 created unrealistic earnings expectations for FY21.

    The Kogan.com Ltd (ASX: KGN) share price joins its embattled peers Redbubble Ltd (ASX: RBL) and Temple & Webster Group Ltd (ASX: TPW) in the bargain bin after falling 20% last week.

    With the Kogan share price falling almost 50% year-to-date to 11-month lows of $10.30, this broker has made the bold call to buy the dip. 

    Why did Kogan fall off a cliff?

    Kogan’s update reflects the broader ongoing reversal of supercharged COVID-19 driven earnings. Morgans has described what the market is currently witnessing as a cycle of tough comparisons to periods with COVID-19 tailwinds and “unlikely to be repeated” sales. 

    Kogan’s update looked promising at face value but revealed that earnings before interest, tax, depreciation and amortisation (EBITDA) fell more than 24% compared to the prior corresponding period.

    As a result of lower customer demand, the company will have to store larger than expected levels of inventory, which could potentially lead to weaker margins in the near term. 

    Credit Suisse rates the Kogan share price as outperform 

    Credit Suisse believes the ongoing difficulties associated with stock levels returning to normal and cycling of strong sales growth is only temporary. Looking past the near-term slowdown, the broker is positive on Kogan’s medium-term outlook and opportunities. 

    Credit Suisse observed that the number of active customers continues to expand, but sales momentum appears to have slowed at a faster rate than expected. The broker retained an outperform rating and reduced its target price from $20.85 to $17.93.  

    With the Kogan share price fetching $10.30 at the time of writing, this represents a significant upside of 69%. 

    Foolish takeaway

    While Credit Suisse has put forth an eye-watering 69% upside to the Kogan share price, investors should also remember the risks of trying to ‘catch the knife’. 

    Shares such as the A2 Milk Company Ltd (ASX: A2M) and AGL Energy Ltd (ASX: AGL) are classic examples of seemingly quality shares that have dipped lower and lower. 

    Where to invest $1,000 right now

    When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

    Scott just revealed what he believes are the five best ASX stocks for investors to buy right now. These stocks are trading at dirt-cheap prices and Scott thinks they are great buys right now.

    *Returns as of February 15th 2021

    More reading

    Kerry Sun has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Kogan.com ltd and Temple & Webster Group Ltd. The Motley Fool Australia owns shares of and has recommended A2 Milk. The Motley Fool Australia has recommended Kogan.com ltd and Temple & Webster Group Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

    The post This broker thinks you should buy the Kogan (ASX:KGN) share price dip appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/2QoCZLC